Stereotactic Ablative Body Radiotherapy for Lung Metastases: Where is the Evidence and What are We Doing With It?

This review provides an overview of the use of stereotactic ablative body radiotherapy (SABR) for pulmonary metastases. The local control rates after SABR are generally >90%. Whether this also translates into a significant improvement in overall survival is the subject of ongoing studies. New exc...

Full description

Bibliographic Details

Published in:	Seminars in radiation oncology Vol. 27; no. 3; pp. 229 - 239
Main Authors:	Siva, Shankar, Slotman, Ben J.
Format:	Journal Article
Language:	English
Published:	United States Elsevier Inc 01.07.2017
Subjects:	Dose Fractionation Hematology, Oncology and Palliative Medicine Humans Immunotherapy Lung Neoplasms - mortality Lung Neoplasms - radiotherapy Lung Neoplasms - secondary Molecular Targeted Therapy Radiology Radiosurgery - methods
ISSN:	1053-4296, 1532-9461, 1532-9461
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!